520 participants
To Compare the Efficacy and Safety of BP102 vs. Avastin® in Combination With Paclitaxel/Carboplatin in First-line Treatment of Advanced or Relapsed NSCLC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-12-27
- Start Date:
- 2018-01-25
- Completion:
- 2019-10-21
Conditions
- Non-small Cell Lung Cancer(NSCLC)
Interventions
- DRUG
No Results Yet